Mismatched Imaging Findings of Prostate Cancer Diagnosis:68 Ga-PSMA PET/CT vs mpMRI
10.1007/s13139-021-00701-x
- Author:
Egesta LOPCI
1
;
Piergiuseppe COLOMBO
;
Massimo LAZZERI
Author Information
1. Nuclear Medicine Unit, IRCCS - Humanitas Research Hospital, Via Manzoni 56, CAP 20089 Rozzano, MI, Italy
- Publication Type:INTERESTING IMAGE
- From:Nuclear Medicine and Molecular Imaging
2021;55(4):199-202
- CountryRepublic of Korea
- Language:English
-
Abstract:
Multiparametric magnetic resonance imaging (mpMRI) is the modality of choice for initial diagnosis of prostate cancer (PCa), including biopsy-naïve patients. Nevertheless, clinicians must be aware of the possibility that up to one-fourth of clinically significant cancers might be missed by the modality. Acknowledgment of this occurrence and the increased availability of 68 Ga-PSMA PET/CT in clinical routine, open the door to new, fascinating, indications for this functional modality in the context of PCa detection. With the case herein illustrated, we report a paradigmatic example of mismatch findings between PET/CT and mpMRI better elucidating the potential indication.
